Logo Asphalion

In2sight kick-off meeting

This week, Asphalion participated in the kick-off meeting of a new EU H2020, the European funded projects, named In2sight, where we will be the regulatory partners through the development of the project.

This week, Asphalion participated in the kick-off meeting of a new EU H2020, the European funded projects, named In2sight, where we will be the regulatory partners through the development of the project.
March 5, 2021

This week, Asphalion participated in the kick-off meeting of a new EU H2020, the European funded projects, named In2sight, where we will be the regulatory partners through the development of the project. Our experts Marta Rayo Lunar, Oriol Penon and Luis Borges attended the meeting.

Routine clinical use of biomaterials requires the reduction of the economical and ethical costs of biocompatibility tests (ISO10993 EU norm) which are unsustainable for small-medium industries and for the society.

In this project, the goal is to foster an unprecedented breakthrough in in-vivo optical imaging that will radically renew the biocompatibility tests of biomaterials. This technology will recast our thinking of biomaterial validation, allowing unprecedented quantitative and longitudinal analyses of the host inflammatory response to the implant.

The project will allow unique quantification of the immune reaction to biomaterials at the cellular level (scientific impact), largely reducing the ethical burden of the research and the costs of biomaterial discovery (economic impact), and will Refine and Reduce protocols for biocompatibility on a single revolutionary device (regulatory impact).

Horizon 2020 is the biggest EU Research and Innovation program ever with nearly €80 billion of funding available over 7 years (2014 to 2020) It promises more breakthroughs, discoveries and world-firsts by taking great ideas from the lab to the market.

For further information, you can contact us at: info@asphalion.com

 

You can read more about the project here:

https://www.in2sight.eu/

Search News & Events

  • Filter by category

Share

Related news and events

RBDCOV PROJECT | PODCAST SERIES

‘RBDCOV Talks’ brings vaccine clinical research closer to the general audience through a podcast series with 10 scientists, clinicians, specialists and community advocates who are partners in the project.

For further information

If you are interested in our services, or wish to get in touch for a general enquiry, please contact us for more information.

Fill the form and we will contact you as soon as possible.

You can also follow us on:

Schedule a Free Meeting

Schedule here a free 30-minutes meeting with one of our consultants and tell us about your project, challenges or doubts. 

We will be happy to assist you!

Schedule a meeting